• The Fund has a policy to invest in investment units of offshore equity funds which the Destination Funds will diversify their investments in securities or financial instruments of companies that benefit from operating businesses related to the new form of healthcare such as Gene Therapy, Telemedicine and Healthcare IT Infrastructure. The Fund will invest in investment units of 2 or more of the aforementioned funds in order to have net exposure averaged in an accounting year not less than 80% of the NAV of the Fund which the investment ratio of each fund averaged in any accounting year shall not exceed 79% of the NAV of the Fund. However, the investment ratio of each fund shall depend on the discretion of the Fund Managers which may be adjusted in accordance with the investment situation or forecast of the investment situation at any given time. The Fund will invest offshore averaged in an accounting year not less than 80% of the NAV of the Fund.
• The Fund may invest in derivatives for efficient portfolio management or for hedging purposes depending on the discretion of the Fund Managers.
• Investment strategy : Active Management